MiR-454-3p-Mediated Wnt/ β -catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis

Conclusions: The findings indicate that miR-454-3p-mediated suppression of Wnt/β-catenin antagonist RPRD1A, as well as AXIN2, DKK3 and SFRP1, sustains the constitutive activation of Wnt/β-catenin signaling; thus, miR-454-3p and RPRD1A might be potential diagnostic and therapeutic targets for breast cancer metastasis.
Source: Theranostics - Category: Molecular Biology Authors: Tags: Research Paper Source Type: research